773097-02-2Relevant academic research and scientific papers
Small molecule thienopyrimidine-based protein tyrosine kinase inhibitors
-
Page/Page column 42, (2010/02/15)
Various thienopyrimidine-based analog compounds are able to selectively inhibit the Src family of tyrosine kinases. These compounds are useful in the treatment of various diseases including hyperproliferative diseases, hematologic diseases, osteoporosis, neurological diseases, autoimmune diseases, allergic/immunological diseases, or viral infections.
